CV Sciences Q1 2025 revenue $3.6M (-10% YoY); turns operating profit $11K

CV Sciences, Inc.

2025-Q1 EPS reported $0.00 revenue$3,606,000

Q1 revenue $3.6M vs $4.0M YoY; unit volume down 11.8%, partially offset by 0.9% price increase.
Operating income of $11K vs $0.6M loss YoY, boosted by $0.5M reversal of accrued payroll taxes.
Adjusted EBITDA loss improved to $0.3M from $0.5M YoY; gross margin 46.0% vs 46.3%.
Launched Lunar Fox plant-based product line with 7 vegan products in U.S. retail and online.
Raised $1.2M net from institutional investor in Q1; cash balance $0.8M vs $0.5M end-2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.